UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1

Historical Holders from Q1 2014 to Q3 2016

Type / Class
Debt / NOTE 1.000% 9/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2016 Q3 $0 $0 -$2,010,000 0
2016 Q2 $909,000 $2,010,000 -$3,762,000 221.12% 1
2016 Q1 $2,528,000 $5,874,000 -$258,148 232.36% 4
2015 Q4 $2,603,000 $8,520,821 -$61,774,000 326.89% 5
2015 Q3 $29,637,000 $78,212,231 -$5,961,782 274.1% 8
2015 Q2 $28,484,000 $103,682,000 -$170,786,539 365.1% 8
2015 Q1 $114,775,000 $413,760,430 -$49,724,354 360.33% 13
2014 Q4 $131,750,000 $367,980,000 -$292,638,485 270.95% 14
2014 Q3 $239,870,400 $646,058,860 +$66,870,578 269.24% 20
2014 Q2 $216,545,400 $407,962,308 -$10,892,832 188.54% 19
2014 Q1 $221,662,400 $439,827,759 -$78,384,822 198.56% 17